- Home
- UTZ vs MYGN Comparison
UTZ vs MYGN Comparison
Compare UTZ & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTZ
- MYGN
- Stock Information
- Founded
- UTZ 2018
- MYGN 1991
- Country
- UTZ United States
- MYGN United States
- Employees
- UTZ N/A
- MYGN N/A
- Industry
- UTZ Packaged Foods
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- UTZ Consumer Staples
- MYGN Health Care
- Exchange
- UTZ Nasdaq
- MYGN Nasdaq
- Market Cap
- UTZ 1.3B
- MYGN 1.2B
- IPO Year
- UTZ N/A
- MYGN 1995
- Fundamental
- Price
- UTZ $14.11
- MYGN $14.18
- Analyst Decision
- UTZ Buy
- MYGN Hold
- Analyst Count
- UTZ 10
- MYGN 13
- Target Price
- UTZ $19.90
- MYGN $22.54
- AVG Volume (30 Days)
- UTZ 1.2M
- MYGN 1.2M
- Earning Date
- UTZ 02-20-2025
- MYGN 02-24-2025
- Dividend Yield
- UTZ 1.92%
- MYGN N/A
- EPS Growth
- UTZ N/A
- MYGN N/A
- EPS
- UTZ 0.19
- MYGN N/A
- Revenue
- UTZ $1,409,281,000.00
- MYGN $823,600,000.00
- Revenue This Year
- UTZ N/A
- MYGN $13.60
- Revenue Next Year
- UTZ $3.07
- MYGN $3.25
- P/E Ratio
- UTZ $74.21
- MYGN N/A
- Revenue Growth
- UTZ N/A
- MYGN 12.15
- 52 Week Low
- UTZ $12.71
- MYGN $12.04
- 52 Week High
- UTZ $20.04
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- UTZ 53.84
- MYGN 55.82
- Support Level
- UTZ $12.83
- MYGN $14.13
- Resistance Level
- UTZ $14.55
- MYGN $15.47
- Average True Range (ATR)
- UTZ 0.47
- MYGN 0.72
- MACD
- UTZ 0.14
- MYGN 0.27
- Stochastic Oscillator
- UTZ 76.05
- MYGN 61.38
About UTZ Utz Brands Inc
Utz Brands Inc is a snack food manufacturing company. It manufactures a diverse portfolio of salty snacks under popular brands including Utz, Zapp's, Golden Flake, Boulder Canyon, Hawaiian, TORTIYAHS!, among others. The company's products include potato chips, tortilla chips, pretzels, cheese snacks, pork skins, veggie snacks, pub/party mixes, and other snacks.. Its products are distributed nationally and internationally through grocery, mass merchant, club, convenience, drug, and other channels. It operates in the given segment: the manufacturing, distribution, marketing and sale of snack food products.
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.